At the IGTP TODAY
Gracias al convenio con la empresa energética la investigadora Noemí Párraga contínua investigando en el proyecto Desarrollo de un sistema automático de captura y detección de Legionella pneumophila en muestras de agua basado en métodos inmunológicos liderado por Dr Miquel Sabrià del Hospital Germans Trias i Pujol y el Instituto de Investigación Germans Trias i Pujol
Manremyc, a biotechnology spin-off of the IGTP is responsable for a huge leap forward in the fight against tuberculosis in developing countries. A new agreement with SRS Life Sciences will make the cheap and easily administered food supplement Nyaditum resae® available to over 5 million people. The food supplement, which can be added to food or taken in pill form has been developed from a harmless bacterium found in water in Catalonia in Spain.
Dr Carolina Armengol has been named as the new leader of the CIBEREHD Group (CB06/04/0033) at the IGTP. She will take over from Dr Ramon Planas who has led the group during many years. Dr Armengol has been working for 18 years on translational research in the field of hepatology, and especially on hepatic cancer.
Es tracta de la segona visita que organitzen als laboratoris de l'Institut Germans Trias
La festa a la Pobla Brasseria a Suria va ser un gran èxit!
23 April 2016. The group led by Dr Antoni Bayés-Genís of the Department of Cardiology of the Germans Trias i Pujol Hospital (HUGTiP) and the Germans Trias i Pujol Health Research Institute (IGTP) have signed a licence agreement with the American Company Critical Diagnostics for biomarker soluble neprilysin (sNEP).
Uno de los principales inconvenientes al que se enfrenta la ciencia para la mejora del tratamiento de la enfermedad inflamatoria intestinal es el desconocimiento de las causas de la enfermedad.
This year Childhood Liver Oncology group (c-LOG), led by Carolina Armengol at the IGTP had the honour of organizing the 3-day meeting. Participants and members of the organization declared the event an overwhelming success and the best yet.
Teresa Gasull, líder del proyecto Apotransferrina, y participante en la primera edición, assiste al acto
Sònia-Vanina Forcales primera classificada amb el projecte "Identificació de biomarcadors cromatínics i predictius de resposta i sensibilització als tractaments actuals en el càncer colorectal"
